Centogene
Lennart S. currently serves as VP Corporate Development, Investor Relations, and Communications at CENTOGENE since October 2019, focusing on delivering data-driven solutions for rare and neurodegenerative diseases. Prior roles at CENTOGENE include Vice President of Corporate Development & Investor Relations, Director of Investor Relations, and Director of Corporate Projects, contributing to the company's mission of transforming clinical, genetic, and multiomic data into actionable medical insights. Lennart S. is also a Guest Lecturer at the International School of Management in Germany. Previously, positions included Prokurist at Identiv and roles in investment management and private equity at Bankhaus Lampe KG and Conetwork Erneuerbare Energien Management GmbH, respectively. Educational qualifications include a Diplomkaufmann in Finance and Accounting from the University of Hamburg and additional studies in law and at KEDGE Business School.
This person is not in any teams
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.